Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Peptides are being billed as the next big breakthrough in wellness, with more people turning to them for weight loss and anti aging. FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
senolytic peptide foxo4-dri human study FOXO4-DRI: The Senolytic Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness